Development of a Robust and Scalable Process for the Large-Scale Preparation of Vadadustat
- 5 March 2021
- journal article
- research article
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 25 (4), 960-968
- https://doi.org/10.1021/acs.oprd.1c00004
Abstract
No abstract availableKeywords
Funding Information
- State Key Laboratory of Anti-Infective Drug Development, HEC Pharm Co., Inc. (2015DQ780357)
This publication has 9 references indexed in Scilit:
- Synthesis and in vitro evaluation of antimycobacterial and cytotoxic activity of new α,β-unsaturated amide, oxazoline and oxazole derivatives from -serineBioorganic & Medicinal Chemistry Letters, 2020
- Prolyl Hydroxylase Inhibitors: A Breakthrough in the Therapy of Anemia Associated with Chronic DiseasesJournal of Medicinal Chemistry, 2018
- HIF‐prolyl hydroxylases as therapeutic targets in erythropoiesis and iron metabolismHemodialysis International, 2017
- Vadadustat, a novel oral HIF stabilizer, provides effective anemia treatment in nondialysis-dependent chronic kidney diseaseKidney International, 2016
- Design, Synthesis, and Biological Evaluation of 14-Heteroaromatic-Substituted Naltrexone Derivatives: Pharmacological Profile Switch from Mu Opioid Receptor Selectivity to Mu/Kappa Opioid Receptor Dual SelectivityJournal of Medicinal Chemistry, 2013
- Dynamic Combinatorial Mass Spectrometry Leads to Inhibitors of a 2-Oxoglutarate-Dependent Nucleic Acid DemethylaseJournal of Medicinal Chemistry, 2012
- Efficient and Selective Demethylation of Heteroaryl Methyl Ethers in the Presence of Aryl Methyl EthersSynthetic Communications, 2011
- Dealkylation of Alkyl and Aryl Ethers with AlCl3- NaI in the Absence of SolventSynthetic Communications, 1999
- Asymmetric synthesis. Metal complex mediated synthesis of chiral glycine by enantioselective proton exchangeJournal of the American Chemical Society, 1986